Loss of GATA6 drives epigenetic cell-identity switch in colorectal cancer metastasis
Reduced activity of the transcription factor GATA6 allows colorectal cancer cells to adopt a fetal-like, highly plastic state capable of seeding liver metastases — driven by epigenetic rather than mutational change.
A study reported by ScienceDaily describes how colorectal cancer cells can undergo a fundamental change in cellular identity without acquiring new genetic mutations. When expression of GATA6, a transcription factor that maintains the normal intestinal cell programme, falls below a critical threshold, cancer cells can transition into a fetal-like, dedifferentiated state. In this state they become highly adaptable — capable of entering the bloodstream and colonising the liver to establish secondary tumours.
The finding highlights a role for epigenetic reprogramming — alterations in which genes are switched on or off, rather than changes in the DNA sequence itself — in driving the metastatic cascade. This distinction is significant for research into colorectal cancer progression: it suggests that certain metastatic transitions may be reversible in principle, and that GATA6 activity could serve as a marker of tumour plasticity in future translational studies.
The original institution, journal, and authors were not identified in the press-release lede available for this summary. Researchers and oncologists interested in the primary data are encouraged to consult the source article directly for methodological detail, cohort characteristics, and statistical findings.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Bowel cancer can sometimes spread to other parts of the body, most commonly the liver. Researchers have found one reason why this happens: a protein called GATA6, which normally helps bowel cells keep their identity, can become less active in cancer cells. When that happens, the cancer cells can transform into a more primitive, adaptable form — similar to cells seen in early development — and travel through the blood to start new tumours elsewhere.
Importantly, this change does not seem to require new DNA mutations. Instead, it involves a different kind of change that affects which genes are switched on or off. Scientists are interested in this because such changes might one day be targeted by new treatments.
This research was reported in the science press; the full details of the journal and research team were not available in the summary reviewed here. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source ScienceDaily · 2026-07-07Scientists discover how colon cancer cells change identity to spread